Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings
Authors
Keywords
-
Journal
EUROPACE
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-07-04
DOI
10.1093/europace/euaa216
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
- (2020) Chih-Cheng Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Association of QT-Prolonging Medications With Risk of Autopsy-Defined Causes of Sudden Death
- (2020) Timothy F. Simpson et al. JAMA Internal Medicine
- Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment
- (2020) Dan M. Roden et al. CIRCULATION
- SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes
- (2020) Cheng-I. Wu et al. HEART RHYTHM
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Nicholas J. Mercuro et al. JAMA Cardiology
- Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit
- (2020) Francis Bessière et al. JAMA Cardiology
- Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature
- (2018) Clotilde Chatre et al. DRUG SAFETY
- Hydroxychloroquine in patients with systemic lupus erythematosus with end-stage renal disease
- (2016) Monique Bethel et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Development and Validation of a Risk Score to Predict QT Interval Prolongation in Hospitalized Patients
- (2013) James E. Tisdale et al.
- Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus
- (2013) R. Alkmim Teixeira et al. EUROPACE
- Hydroxychloroquine: From Malaria to Autoimmunity
- (2011) Ilan Ben-Zvi et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now